Clinical Trial Update: Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document describes a Phase Ib trial of HS-20117 in combination with other drugs for advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• HS-20117

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Solid Tumors, Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING